ERBB2 and breast carcinoma: Interestingly our analysis demonstrated significant expression differences for only CCM1, CCM3, and nPRs (Fig. 1C) in luminal-type breast cancers, based on HER2 expression, suggesting a novel relationship between expression levels for these three genes and HER2 expression.